254 related articles for article (PubMed ID: 17149881)
1. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
[TBL] [Abstract][Full Text] [Related]
2. 1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
Jeppesen L; Olesen PH; Hansen L; Sheardown MJ; Thomsen C; Rasmussen T; Jensen AF; Christensen MS; Rimvall K; Ward JS; Whitesitt C; Calligaro DO; Bymaster FP; Delapp NW; Felder CC; Shannon HE; Sauerberg P
J Med Chem; 1999 Jun; 42(11):1999-2006. PubMed ID: 10354408
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.
Sauerberg P; Jeppesen L; Olesen PH; Rasmussen T; Swedberg MD; Sheardown MJ; Fink-Jensen A; Thomsen C; Thøgersen H; Rimvall K; Ward JS; Calligaro DO; DeLapp NW; Bymaster FP; Shannon HE
J Med Chem; 1998 Oct; 41(22):4378-84. PubMed ID: 9784113
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.
Cao Y; Zhang M; Wu C; Lee S; Wroblewski ME; Whipple T; Nagy PI; Takács-Novák K; Balázs A; Torös S; Messer WS
J Med Chem; 2003 Sep; 46(20):4273-86. PubMed ID: 13678406
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 1,2,5-thiadiazoles as modulators of M₁/M₅ muscarinic receptor subtypes.
Maheshwari A; Rao PS; Messer WS
Bioorg Med Chem; 2014 Mar; 22(6):1838-44. PubMed ID: 24582400
[TBL] [Abstract][Full Text] [Related]
6. Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.
Sauerberg P; Olesen PH; Sheardown MJ; Rimvall K; Thøgersen H; Shannon HE; Sawyer BD; Ward JS; Bymaster FP; DeLapp NW; Calligaro DO; Swedberg MD
J Med Chem; 1998 Jan; 41(1):109-16. PubMed ID: 9438027
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists.
Rajeswaran WG; Cao Y; Huang XP; Wroblewski ME; Colclough T; Lee S; Liu F; Nagy PI; Ellis J; Levine BA; Nocka KH; Messer WS
J Med Chem; 2001 Dec; 44(26):4563-76. PubMed ID: 11741475
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
9. 1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonists.
Ward JS; Merritt L; Calligaro DO; Bymaster FP; Shannon HE; Mitch CH; Whitesitt C; Brunsting D; Sheardown MJ; Olesen PH; Swedberg MD; Jeppesen L; Sauerberg P
J Med Chem; 1998 Jan; 41(3):379-92. PubMed ID: 9464368
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonists.
Christopoulos A; Grant MK; Ayoubzadeh N; Kim ON; Sauerberg P; Jeppesen L; El-Fakahany EE
J Pharmacol Exp Ther; 2001 Sep; 298(3):1260-8. PubMed ID: 11504829
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological characterization of O-alkynyloximes of tropinone and N-methylpiperidinone as muscarinic agonists.
Xu R; Sim MK; Go ML
J Med Chem; 1998 Aug; 41(17):3220-31. PubMed ID: 9703467
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 5-(4-alkylsulfanyl-[1, 2, 5]thiadiazol-3-yl)-3-methyl-1, 2, 3, 4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists.
Jung MH; Park JG; Park WK
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):230-5. PubMed ID: 12916057
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
[TBL] [Abstract][Full Text] [Related]
14. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
[TBL] [Abstract][Full Text] [Related]
15. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
Selent J; Brandt W; Pamperin D; Göber B
Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
17. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
[TBL] [Abstract][Full Text] [Related]
18. Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
Messer WS; Rajeswaran WG; Cao Y; Zhang HJ; el-Assadi AA; Dockery C; Liske J; O'Brien J; Williams FE; Huang XP; Wroblewski ME; Nagy PI; Peseckis SM
Pharm Acta Helv; 2000 Mar; 74(2-3):135-40. PubMed ID: 10812950
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.
Hemrick-Luecke SK; Bymaster FP; Evans DC; Wess J; Felder CC
J Pharmacol Exp Ther; 2002 Oct; 303(1):99-103. PubMed ID: 12235238
[TBL] [Abstract][Full Text] [Related]
20. M4 agonists/5HT7 antagonists with potential as antischizophrenic drugs: serominic compounds.
Suckling CJ; Murphy JA; Khalaf AI; Zhou SZ; Lizos DE; van Nhien AN; Yasumatsu H; McVie A; Young LC; McCraw C; Waterman PG; Morris BJ; Pratt JA; Harvey AL
Bioorg Med Chem Lett; 2007 May; 17(9):2649-55. PubMed ID: 17317171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
